EZH2 and cancer: Some have proposed that DZNep, by reducing EZH2 activity and H3K27 trimethylation, a mark of heterochromatin, may induce a loss of chromatin compaction, which could favour DNA damage induced by conventional cytotoxic drugs (such as platinum compounds) and consequently reduce the survival of cancer cells.